The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis

PURPOSE: To explore the predictive efficacy of tumor mutation burden (TMB) as a potential biomarker for cancer patients treated with Immune checkpoint inhibitors (ICIs). METHODS: We systematically searched PubMed, Cochrane Library, Embase and Web of Science for clinical studies (published between Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jinlong, Yang, Xin, Chen, Siyu, Wang, Jirong, Fan, Xinpeng, Fu, Shengjun, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956924/
https://www.ncbi.nlm.nih.gov/pubmed/35339028
http://dx.doi.org/10.1016/j.tranon.2022.101375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956924/
https://www.ncbi.nlm.nih.gov/pubmed/35339028
http://dx.doi.org/10.1016/j.tranon.2022.101375

Ejemplares similares